Is DMSO Toxic? Hazards, Side Effects & Exposure Limits Explained
An evidence-based look at what DMSO does and doesn't do to humans - built for procurement, EHS, and formulation teams.
Is dimethyl sulfoxide (DMSO, CAS 67-68-5) toxic? The honest answer: not very, by the standards of the chemical industry. DMSO has one of the lowest acute toxicity profiles among industrial aprotic solvents - oral LD50 in rats is roughly twice that of ethanol - and it is not classified as a carcinogen, mutagen, or reproductive toxicant by IARC, NTP, OSHA, ACGIH, or under EU CLP. That contrasts sharply with DMF and NMP, both of which are classified as Reproductive Toxicant Category 1B in the EU and are now under REACH Annex XVII restriction.
But "not very toxic" is not the same as "harmless." Three real concerns deserve attention from anyone procuring or handling DMSO: the famous skin penetration / carrier effect, eye-lens findings in long-term animal studies, and a small set of clinically documented drug interactions in topical use. This article walks through the actual toxicology data, the regulatory classifications, and a practical buyer-side checklist. For complementary handling guidance see our DMSO SDS & PPE article.
01. Acute Toxicity - LD50 Data 📊
The most direct way to answer "is DMSO toxic" is to look at how much you would need to give an animal to harm half the test population - the lethal dose 50 % (LD50). The published values for DMSO are unusually high, meaning the substance has unusually low acute toxicity.
| Species & Route | Reported LD50 | Interpretation |
|---|---|---|
| Rat - oral | 14,500 – 28,300 mg/kg | "Practically non-toxic" by GHS criteria (LD50 > 5,000 mg/kg) |
| Mouse - oral | 16,500 – 24,600 mg/kg | Same - extremely low acute oral toxicity |
| Rat - dermal | ~40,000 mg/kg | Very low dermal toxicity for the molecule itself (separate from carrier risk) |
| Mouse - dermal | ~50,000 mg/kg | Same range |
| Rat - inhalation | LC50 ~5,330 mg/m³ | Low inhalation hazard at room temperature (low vapor pressure) |
| Rat - intravenous | 5,000 – 8,000 mg/kg | Lower than oral but still very high relative to most drugs and solvents |
| Rhesus monkey - oral NOEL | 3,300 mg/kg/day for 18 months | No tumors or bone-marrow effects observed |
For comparison, sodium chloride (table salt) has an oral LD50 in rats of about 3,000 mg/kg, and ethanol's is around 7,000 mg/kg. By that metric DMSO is, milligram-for-milligram, roughly four times less acutely toxic than table salt and twice less than ethanol.
02. DMSO vs Other Industrial Solvents ⚖️
DMSO's competitive advantage is sharpest when its toxicology is set side-by-side with the other polar aprotic solvents formulators reach for.
| Solvent | Rat oral LD50 | EU CLP Reproductive Tox | REACH Restriction |
|---|---|---|---|
| DMSO | ~14,500 – 28,300 mg/kg | Not classified | None |
| DMF (N,N-dimethylformamide) | ~2,800 mg/kg | Repr. 1B (H360D) | Annex XVII Entry 76 (in force) |
| NMP (N-methyl-2-pyrrolidone) | ~3,900 mg/kg | Repr. 1B (H360D) | Annex XVII Entry 71 |
| DMAc (N,N-dimethylacetamide) | ~4,930 mg/kg | Repr. 1B (H360D) | Joint REACH dossier (with NEP) |
| Acetonitrile | ~2,460 mg/kg | Not classified | None |
| Methanol | ~5,600 mg/kg | Not classified* | Optical-blindness hazard noted |
| Ethanol (reference) | ~7,060 mg/kg | Not classified | None |
Two patterns stand out. First, DMSO has the highest oral LD50 in this set - by a wide margin. Second, the three amide-based aprotic solvents (DMF, DMAc, NMP) all carry EU reproductive-toxicant classifications that DMSO does not. As regulatory pressure on the amide solvents continues to tighten, DMSO is increasingly the preferred substitute in pharma, electronics, and personal-care formulations.
03. The Garlic-Taste Phenomenon 👃
The single most distinctive subjective effect of DMSO exposure isn't pain or irritation - it's a garlic, oyster, or sulfur taste in the mouth, appearing 15–60 minutes after skin contact and persisting for several hours. Roughly 30–50 % of healthy adults experience it noticeably; some find it strong, others barely register it.
The mechanism: a small fraction of dermally absorbed DMSO is metabolized to dimethyl sulfide (DMS), which is volatile, sulfurous, and excreted partly through breath and saliva. The taste persists until the body finishes clearing the absorbed dose. This metabolic pathway also explains why DMSO breath odor is a classic clinical sign of recent exposure.
Importantly: the garlic taste is harmless - but it is also a useful sensor. If a worker reports the taste, dermal absorption has measurably occurred, and PPE practice should be reviewed.
04. Skin & Eye Effects 👁️
Skin. DMSO causes mild-to-moderate skin irritation on direct contact - usually transient redness, warmth, and occasionally itching at the application site. It is not a skin sensitizer; it does not cause allergic dermatitis. Frequent or large-volume exposures may produce reddening, scaling, or chemical burns. Reactions resolve within hours of removing the source. Concentrated DMSO (≥80 %) is more irritating than dilute aqueous solutions.
Eyes. Direct contact with liquid DMSO causes serious eye irritation - burning, stinging, redness, lacrimation. Most SDSs assign GHS Eye Irritation Category 2. Damage is reversible with prompt and thorough water flushing.
Inhalation. Vapor at room temperature is minimal due to DMSO's low vapor pressure (~0.6 hPa at 25 °C). At elevated handling temperatures or in poorly ventilated areas, vapor exposure can cause respiratory irritation, headache, and nausea - symptoms typically resolve in fresh air within 30 minutes.
Systemic effects from large exposures. Reports following intentional or accidental high-dose exposure (typically clinical, not industrial) include sedation, dizziness, headache, nausea, and a mild diuretic effect. None of these are seen at industrial-handling exposure levels with proper PPE.
05. Carcinogenicity, Mutagenicity & Reproductive Toxicity 🧬
The clearest summary of DMSO's regulatory toxicology status:
| Endpoint | Status | Source |
|---|---|---|
| Carcinogenicity | Not classified as carcinogen | IARC, NTP, OSHA, ACGIH, EU CLP |
| Mutagenicity | Not classified - Ames test negative; standard genotoxicity battery negative | EU CLP, ECHA registration dossier |
| Reproductive toxicity | Not classified | EU CLP, ECHA |
| Developmental toxicity | Not classified at industrial-relevant doses; some animal studies show effects only at very high (≥1 g/kg) injected doses | EU CLP |
| Skin sensitization | Not classified - does not cause allergic contact dermatitis | EU CLP, ECHA |
Importantly, this clean toxicology profile is supported by long-running animal studies, not just acute LD50 data. The 18-month rhesus monkey study at 3,300 mg/kg/day oral DMSO showed no tumors and normal bone-marrow histology, and a 2-year dog study found minor body-weight and hematology changes but no carcinogenic findings. Multi-decade clinical use in DMSO-containing approved drugs (Pennsaid for osteoarthritis, Onyx for embolization, RIMSO-50 for interstitial cystitis) provides additional human safety data.
06. Occupational Exposure Limits 🏭
DMSO does not have a regulatory occupational exposure limit set by OSHA (no PEL) or ACGIH (no TLV). This is because the regulatory bodies have judged DMSO's toxicity to be too low to warrant a numerical limit, not because it has been overlooked.
That said, several jurisdictions and DMSO suppliers publish recommended internal limits:
- Sweden: 50 ppm TWA (regional regulatory limit)
- Russia / former CIS: 50 mg/m³ TWA (~16 ppm)
- Most DMSO suppliers (recommended internal): 50 – 100 ppm TWA
- Skin notation: not assigned by ACGIH but recommended by many EHS organizations because of dermal absorption potential
For practical purposes: with adequate local exhaust ventilation and butyl-rubber gloves for skin contact (see DMSO SDS & PPE article), industrial exposure to DMSO at room temperature is well below any health-relevant level.
07. Eye Lens - The One Real Target Organ 👁️
One specific finding has appeared consistently across long-term animal studies: at very high chronic doses, DMSO can cause changes in the lenticular nucleus of the eye lens. The classic 1975 study by Smith and colleagues, published in Food and Cosmetics Toxicology, dosed dogs orally at 9 mL/kg/day of 50 % DMSO for two years, and dogs / pigs dermally with 50 – 90 % DMSO solutions for 6 – 18 months. Hematology and body-weight changes were minor; the consistent finding was lenticular changes in the eye lens.
Practical relevance:
- The doses required to produce the lens effect in animals (multiple grams per kg per day for many months) are orders of magnitude above any plausible occupational human exposure.
- Importantly, when DMSO products were initially under FDA review for human use, this lens finding was a major concern, but follow-up studies in humans receiving DMSO topically or intravesically did not show similar lens changes at therapeutic doses.
- The mechanism is thought to involve disruption of lens-protein crystallin structure by high-concentration DMSO, not direct toxicity to lens cells.
08. Drug Interactions in Topical Use 💊
Because DMSO so effectively penetrates skin, applying DMSO in combination with another medication or chemical can carry that second substance into the bloodstream at much higher rates than expected. This is the deliberate basis of approved DMSO formulations like Pennsaid (topical diclofenac in 45.5 % DMSO carrier) - but it is also a concern when DMSO is used outside approved formulations.
Documented drug interaction concerns from clinical literature:
- Anticoagulants (warfarin, heparin): increased bleeding risk via enhanced absorption
- Insulin: theoretical enhanced absorption - caution if applied near injection sites
- Topical steroids: systemic exposure can increase substantially
- Topical pesticides / industrial chemicals on skin: if DMSO touches skin already wetted with another solvent, dermal absorption of that second solvent increases dramatically
For B2B contexts, the takeaway is simple: never use DMSO of unknown purity for any human-skin application. Industrial-grade DMSO containing trace impurities will carry those impurities into the body. Pharmaceutical-grade DMSO with batch-specific COA documentation is the only acceptable specification for any topical, cosmetic, or in-vivo application.
09. Buyer Checklist for Safer Sourcing ✅
For procurement and EHS managers evaluating DMSO suppliers, six items separate good practice from poor:
- ✅ Match grade to use case. Industrial reaction solvent → technical ≥99.5 %. Pharma intermediate → USP / EP. Personal care → cosmetic-grade ≥99.9 %. Lab / cell culture → sterile-filtered hybridoma-suitable. Buying pharma-grade for an industrial process wastes money; buying technical-grade for a topical application risks serious harm.
- ✅ Always require a batch-specific COA. A generic spec sheet is not a COA. The COA should list GC purity, water content (Karl Fischer), color (APHA), refractive index, density, and (for pharma / cosmetic) residual-solvent panel and heavy-metal limits.
- ✅ Verify supplier classification of skin/eye irritation. Reputable suppliers classify GHS H315 / H319 / H335 conservatively; absence of these on a supplier's SDS may indicate insufficient classification rigor.
- ✅ Confirm REACH / TSCA / DSL inventory listing for your import country.
- ✅ Reject yellow / off-color material. Fresh DMSO is water-clear (APHA ≤ 20). Yellowing indicates impurities or oxidative degradation - both increase real-world risk.
- ✅ Train workers on the skin-permeation rule. The most common DMSO incidents in industry are not direct toxicity exposures - they're cases where a worker's skin contacts DMSO that has dissolved another chemical from a process.
Frequently Asked Questions
DMSO has very low acute toxicity - oral LD50 in rats is 14,500–28,300 mg/kg, comparable to or lower than table salt. It is not classified as a carcinogen, mutagen, or reproductive toxicant by IARC, NTP, OSHA, ACGIH, or under EU CLP. The main practical concern is its rapid skin penetration, which can carry dissolved contaminants into the body. Used with proper PPE and pure-grade material, DMSO has a strong safety record across decades of industrial and clinical use.
No. DMSO is not classified as a carcinogen by any major regulatory body - IARC, NTP, OSHA, ACGIH, or the EU CLP. Long-term animal studies (including 18-month rhesus monkey and 2-year dog studies) have found no tumor formation. Standard genotoxicity tests (Ames, in vitro mammalian) are negative.
For industrial handling: mild skin irritation, eye irritation if splashed, the characteristic garlic / sulfur taste in mouth from skin contact, occasional headache or nausea from large vapor exposures. For clinical / topical use at high concentrations: same plus possible mild sedation, diuresis, and the lens findings reported in long-term animal studies (not seen in humans at therapeutic doses).
Pharmaceutical-grade DMSO with full COA documentation is used in FDA-approved topical drugs (Pennsaid, RIMSO-50). Industrial- or technical-grade DMSO is not safe for skin application - it may contain impurities that DMSO will carry through skin into the bloodstream. The grade you specify dictates the safety profile.
Yes, substantially. DMF, DMAc, and NMP are all classified Reproductive Toxicant Category 1B in the EU; DMSO is not classified for reproductive toxicity. NMP and DMF are restricted under REACH Annex XVII; DMSO has no such restriction. DMSO's oral LD50 is roughly 5× higher than DMF and 4× higher than NMP. This is a major reason for the ongoing migration from amide aprotic solvents to DMSO in pharma and electronics.
There is no OSHA PEL or ACGIH TLV for DMSO. Sweden has set 50 ppm TWA; Russia / CIS countries have set 50 mg/m³. Most DMSO suppliers recommend an internal limit of 50–100 ppm TWA. With adequate ventilation at room-temperature handling, vapor exposures stay well below any health-relevant concentration.
📚 Authoritative References
- PubChem - DMSO Toxicity & Hazards (CID 679)
- ECHA - DMSO REACH Registration Dossier (CAS 67-68-5)
- IARC Monographs - Carcinogen Classifications Database
- PubMed - Smith et al. - Toxicity of DMSO in dog, pig, rat and rabbit
- NCBI PMC - DMSO LD50 Compilation Across Species & Routes
- U.S. FDA - Inactive Ingredient Database (DMSO entries in approved drugs)
🔗 Continue Reading - DMSO Knowledge Hub
DMSO with Full Toxicology Documentation & Batch COA
Sinolook Chemical Co., Ltd. supplies dimethyl sulfoxide (CAS 67-68-5) with full GHS-compliant SDS, batch-specific COA, and grade-matched documentation - technical, anhydrous, USP / pharmaceutical, cosmetic, and lab grades. Packed in 250 kg drums, 1100 kg IBCs, and ISO tanks for 50+ countries.
